nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2E1—Fingolimod—multiple sclerosis	0.128	0.197	CbGbCtD
Bupropion—CYP2A6—Prednisolone—multiple sclerosis	0.0805	0.123	CbGbCtD
Bupropion—CYP2D6—Fingolimod—multiple sclerosis	0.0612	0.0937	CbGbCtD
Bupropion—CYP2E1—Mitoxantrone—multiple sclerosis	0.0604	0.0925	CbGbCtD
Bupropion—CYP2A6—Dexamethasone—multiple sclerosis	0.0474	0.0726	CbGbCtD
Bupropion—CYP3A4—Fingolimod—multiple sclerosis	0.0389	0.0596	CbGbCtD
Bupropion—CYP2E1—Dexamethasone—multiple sclerosis	0.0313	0.0479	CbGbCtD
Bupropion—CYP2B6—Dexamethasone—multiple sclerosis	0.0309	0.0473	CbGbCtD
Bupropion—CYP3A4—Methylprednisolone—multiple sclerosis	0.0251	0.0384	CbGbCtD
Bupropion—CYP2C8—Dexamethasone—multiple sclerosis	0.0234	0.0358	CbGbCtD
Bupropion—CYP3A4—Triamcinolone—multiple sclerosis	0.019	0.0291	CbGbCtD
Bupropion—CYP3A4—Mitoxantrone—multiple sclerosis	0.0183	0.028	CbGbCtD
Bupropion—CYP2C9—Dexamethasone—multiple sclerosis	0.0163	0.025	CbGbCtD
Bupropion—CYP3A4—Betamethasone—multiple sclerosis	0.0163	0.025	CbGbCtD
Bupropion—CYP3A4—Prednisolone—multiple sclerosis	0.0161	0.0246	CbGbCtD
Bupropion—CYP3A4—Prednisone—multiple sclerosis	0.0152	0.0233	CbGbCtD
Bupropion—CYP2D6—Dexamethasone—multiple sclerosis	0.0149	0.0228	CbGbCtD
Bupropion—CYP3A4—Dexamethasone—multiple sclerosis	0.00949	0.0145	CbGbCtD
Bupropion—SLC6A3—nerve—multiple sclerosis	0.00178	0.0986	CbGeAlD
Bupropion—SLC6A2—nerve—multiple sclerosis	0.00143	0.0795	CbGeAlD
Bupropion—CHRNA3—retina—multiple sclerosis	0.00133	0.0738	CbGeAlD
Bupropion—SLC6A3—brainstem—multiple sclerosis	0.000763	0.0423	CbGeAlD
Bupropion—CHRNA3—nervous system—multiple sclerosis	0.000723	0.0401	CbGeAlD
Bupropion—CHRNA3—central nervous system—multiple sclerosis	0.000696	0.0386	CbGeAlD
Bupropion—CHRNA3—cerebellum—multiple sclerosis	0.000681	0.0377	CbGeAlD
Bupropion—SLC6A2—brainstem—multiple sclerosis	0.000616	0.0341	CbGeAlD
Bupropion—CHRNA3—brain—multiple sclerosis	0.000553	0.0306	CbGeAlD
Bupropion—ORM1—spinal cord—multiple sclerosis	0.00051	0.0283	CbGeAlD
Bupropion—SLC6A3—midbrain—multiple sclerosis	0.000487	0.027	CbGeAlD
Bupropion—SLC6A3—spinal cord—multiple sclerosis	0.000475	0.0263	CbGeAlD
Bupropion—CYP2A6—cerebellum—multiple sclerosis	0.000444	0.0246	CbGeAlD
Bupropion—ORM1—nervous system—multiple sclerosis	0.00043	0.0238	CbGeAlD
Bupropion—SLC6A2—medulla oblongata—multiple sclerosis	0.000429	0.0238	CbGeAlD
Bupropion—ORM1—central nervous system—multiple sclerosis	0.000414	0.023	CbGeAlD
Bupropion—SLC6A3—nervous system—multiple sclerosis	0.0004	0.0222	CbGeAlD
Bupropion—SLC6A3—central nervous system—multiple sclerosis	0.000385	0.0213	CbGeAlD
Bupropion—SLC6A3—cerebellum—multiple sclerosis	0.000376	0.0209	CbGeAlD
Bupropion—CYP2A6—brain—multiple sclerosis	0.000361	0.02	CbGeAlD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00035	0.011	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00035	0.011	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000348	0.0109	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000348	0.0109	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000343	0.0108	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000343	0.0108	CbGpPWpGaD
Bupropion—CYP2D6—brainstem—multiple sclerosis	0.000337	0.0187	CbGeAlD
Bupropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00033	0.0104	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000329	0.0104	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000329	0.0104	CbGpPWpGaD
Bupropion—SLC6A2—nervous system—multiple sclerosis	0.000323	0.0179	CbGeAlD
Bupropion—SLC6A2—central nervous system—multiple sclerosis	0.000311	0.0172	CbGeAlD
Bupropion—SLC6A3—brain—multiple sclerosis	0.000306	0.0169	CbGeAlD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000301	0.00945	CbGpPWpGaD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000301	0.00945	CbGpPWpGaD
Bupropion—CYP2E1—medulla oblongata—multiple sclerosis	0.000297	0.0165	CbGeAlD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000297	0.00933	CbGpPWpGaD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000297	0.00933	CbGpPWpGaD
Bupropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000292	0.0092	CbGpPWpGaD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000288	0.00905	CbGpPWpGaD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000288	0.00905	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000282	0.00887	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000282	0.00887	CbGpPWpGaD
Bupropion—CYP2E1—spinal cord—multiple sclerosis	0.000265	0.0147	CbGeAlD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000254	0.00799	CbGpPWpGaD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000254	0.00799	CbGpPWpGaD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000247	0.00776	CbGpPWpGaD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000247	0.00776	CbGpPWpGaD
Bupropion—SLC6A2—brain—multiple sclerosis	0.000247	0.0137	CbGeAlD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000245	0.00769	CbGpPWpGaD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000245	0.00769	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000244	0.00766	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000244	0.00766	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000244	0.00766	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000244	0.00766	CbGpPWpGaD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000241	0.00759	CbGpPWpGaD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000241	0.00759	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—KCNA3—multiple sclerosis	0.000239	0.00752	CbGpPWpGaD
Bupropion—CYP2B6—nervous system—multiple sclerosis	0.000238	0.0132	CbGeAlD
Bupropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000231	0.00726	CbGpPWpGaD
Bupropion—CYP2B6—central nervous system—multiple sclerosis	0.000229	0.0127	CbGeAlD
Bupropion—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000225	0.00708	CbGpPWpGaD
Bupropion—CYP2E1—nervous system—multiple sclerosis	0.000223	0.0124	CbGeAlD
Bupropion—CYP2E1—central nervous system—multiple sclerosis	0.000215	0.0119	CbGeAlD
Bupropion—CYP2E1—cerebellum—multiple sclerosis	0.00021	0.0116	CbGeAlD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000209	0.00658	CbGpPWpGaD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000209	0.00658	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000206	0.00649	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000206	0.00649	CbGpPWpGaD
Bupropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000204	0.00643	CbGpPWpGaD
Bupropion—CYP2C8—brain—multiple sclerosis	0.000203	0.0112	CbGeAlD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0002	0.00629	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0002	0.00629	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000198	0.00624	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000198	0.00624	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000198	0.00623	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.00019	0.00596	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.00019	0.00596	CbGpPWpGaD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000183	0.00576	CbGpPWpGaD
Bupropion—CYP2B6—brain—multiple sclerosis	0.000182	0.0101	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000181	0.0057	CbGpPWpGaD
Bupropion—CYP3A4—nervous system—multiple sclerosis	0.00018	0.00995	CbGeAlD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000179	0.00564	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000179	0.00564	CbGpPWpGaD
Bupropion—CYP2D6—nervous system—multiple sclerosis	0.000177	0.00979	CbGeAlD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000175	0.00552	CbGpPWpGaD
Bupropion—CYP3A4—central nervous system—multiple sclerosis	0.000173	0.00958	CbGeAlD
Bupropion—CYP2E1—brain—multiple sclerosis	0.000171	0.00945	CbGeAlD
Bupropion—CYP2D6—central nervous system—multiple sclerosis	0.00017	0.00943	CbGeAlD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00017	0.00533	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00017	0.00533	CbGpPWpGaD
Bupropion—CYP2D6—cerebellum—multiple sclerosis	0.000166	0.00922	CbGeAlD
Bupropion—SLC6A2—Monoamine Transport—IL1B—multiple sclerosis	0.000164	0.00516	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000161	0.00507	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000161	0.00507	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000159	0.00501	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000159	0.00501	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000153	0.00481	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000153	0.00481	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000151	0.00474	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000151	0.00474	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00015	0.00472	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.00015	0.00471	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.00015	0.00471	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000148	0.00465	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000148	0.00465	CbGpPWpGaD
Bupropion—SLC6A3—Monoamine Transport—IL1B—multiple sclerosis	0.000145	0.00457	CbGpPWpGaD
Bupropion—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000145	0.00455	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—BCHE—multiple sclerosis	0.000139	0.00436	CbGpPWpGaD
Bupropion—CYP2D6—brain—multiple sclerosis	0.000135	0.00749	CbGeAlD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000133	0.00418	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000131	0.00411	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000131	0.00411	CbGpPWpGaD
Bupropion—Mental disorder—Prednisone—multiple sclerosis	0.00013	0.000436	CcSEcCtD
Bupropion—Nausea—Azathioprine—multiple sclerosis	0.000129	0.000436	CcSEcCtD
Bupropion—Tachycardia—Methylprednisolone—multiple sclerosis	0.000129	0.000436	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000129	0.00407	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000129	0.00407	CbGpPWpGaD
Bupropion—Skin disorder—Methylprednisolone—multiple sclerosis	0.000129	0.000434	CcSEcCtD
Bupropion—Malnutrition—Prednisone—multiple sclerosis	0.000129	0.000434	CcSEcCtD
Bupropion—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000129	0.000433	CcSEcCtD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—STAT3—multiple sclerosis	0.000128	0.00404	CbGpPWpGaD
Bupropion—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000128	0.000432	CcSEcCtD
Bupropion—Convulsion—Betamethasone—multiple sclerosis	0.000128	0.000431	CcSEcCtD
Bupropion—Convulsion—Dexamethasone—multiple sclerosis	0.000128	0.000431	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000128	0.00402	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000128	0.00402	CbGpPWpGaD
Bupropion—Hypertension—Dexamethasone—multiple sclerosis	0.000128	0.00043	CcSEcCtD
Bupropion—Hypertension—Betamethasone—multiple sclerosis	0.000128	0.00043	CcSEcCtD
Bupropion—Asthenia—Mitoxantrone—multiple sclerosis	0.000126	0.000426	CcSEcCtD
Bupropion—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000126	0.00397	CbGpPWpGaD
Bupropion—Myalgia—Betamethasone—multiple sclerosis	0.000126	0.000424	CcSEcCtD
Bupropion—Myalgia—Dexamethasone—multiple sclerosis	0.000126	0.000424	CcSEcCtD
Bupropion—Anxiety—Dexamethasone—multiple sclerosis	0.000125	0.000422	CcSEcCtD
Bupropion—Anxiety—Betamethasone—multiple sclerosis	0.000125	0.000422	CcSEcCtD
Bupropion—Discomfort—Betamethasone—multiple sclerosis	0.000124	0.000419	CcSEcCtD
Bupropion—Discomfort—Dexamethasone—multiple sclerosis	0.000124	0.000419	CcSEcCtD
Bupropion—Haemoglobin—Methotrexate—multiple sclerosis	0.000124	0.000418	CcSEcCtD
Bupropion—Hypotension—Methylprednisolone—multiple sclerosis	0.000124	0.000418	CcSEcCtD
Bupropion—Pain—Prednisolone—multiple sclerosis	0.000124	0.000416	CcSEcCtD
Bupropion—Haemorrhage—Methotrexate—multiple sclerosis	0.000124	0.000416	CcSEcCtD
Bupropion—Hepatitis—Methotrexate—multiple sclerosis	0.000124	0.000416	CcSEcCtD
Bupropion—Pharyngitis—Methotrexate—multiple sclerosis	0.000123	0.000413	CcSEcCtD
Bupropion—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000122	0.000411	CcSEcCtD
Bupropion—Vision blurred—Prednisone—multiple sclerosis	0.000121	0.000409	CcSEcCtD
Bupropion—Urethral disorder—Methotrexate—multiple sclerosis	0.000121	0.000408	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000121	0.000408	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000121	0.000407	CcSEcCtD
Bupropion—Oedema—Betamethasone—multiple sclerosis	0.000121	0.000406	CcSEcCtD
Bupropion—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000121	0.000406	CcSEcCtD
Bupropion—Oedema—Dexamethasone—multiple sclerosis	0.000121	0.000406	CcSEcCtD
Bupropion—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000121	0.000406	CcSEcCtD
Bupropion—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000121	0.000406	CcSEcCtD
Bupropion—Insomnia—Triamcinolone—multiple sclerosis	0.00012	0.000405	CcSEcCtD
Bupropion—Insomnia—Methylprednisolone—multiple sclerosis	0.00012	0.000404	CcSEcCtD
Bupropion—Infection—Betamethasone—multiple sclerosis	0.00012	0.000404	CcSEcCtD
Bupropion—Infection—Dexamethasone—multiple sclerosis	0.00012	0.000404	CcSEcCtD
Bupropion—Ill-defined disorder—Prednisone—multiple sclerosis	0.000119	0.000402	CcSEcCtD
Bupropion—Paraesthesia—Triamcinolone—multiple sclerosis	0.000119	0.000402	CcSEcCtD
Bupropion—Feeling abnormal—Prednisolone—multiple sclerosis	0.000119	0.000401	CcSEcCtD
Bupropion—SLC6A2—Monoamine Transport—TNF—multiple sclerosis	0.000119	0.00375	CbGpPWpGaD
Bupropion—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000119	0.000401	CcSEcCtD
Bupropion—Visual impairment—Methotrexate—multiple sclerosis	0.000119	0.000401	CcSEcCtD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—TGFB1—multiple sclerosis	0.000119	0.00374	CbGpPWpGaD
Bupropion—Anaemia—Prednisone—multiple sclerosis	0.000119	0.000401	CcSEcCtD
Bupropion—Shock—Dexamethasone—multiple sclerosis	0.000119	0.0004	CcSEcCtD
Bupropion—Shock—Betamethasone—multiple sclerosis	0.000119	0.0004	CcSEcCtD
Bupropion—Dyspnoea—Triamcinolone—multiple sclerosis	0.000119	0.000399	CcSEcCtD
Bupropion—Nervous system disorder—Betamethasone—multiple sclerosis	0.000118	0.000398	CcSEcCtD
Bupropion—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000118	0.000398	CcSEcCtD
Bupropion—Agitation—Prednisone—multiple sclerosis	0.000118	0.000398	CcSEcCtD
Bupropion—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000118	0.000398	CcSEcCtD
Bupropion—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000118	0.000398	CcSEcCtD
Bupropion—Tachycardia—Betamethasone—multiple sclerosis	0.000118	0.000397	CcSEcCtD
Bupropion—Tachycardia—Dexamethasone—multiple sclerosis	0.000118	0.000397	CcSEcCtD
Bupropion—Angioedema—Prednisone—multiple sclerosis	0.000118	0.000396	CcSEcCtD
Bupropion—Dyspepsia—Triamcinolone—multiple sclerosis	0.000117	0.000394	CcSEcCtD
Bupropion—Erythema multiforme—Methotrexate—multiple sclerosis	0.000117	0.000394	CcSEcCtD
Bupropion—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000117	0.000393	CcSEcCtD
Bupropion—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000117	0.000393	CcSEcCtD
Bupropion—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000117	0.000393	CcSEcCtD
Bupropion—Malaise—Prednisone—multiple sclerosis	0.000116	0.000391	CcSEcCtD
Bupropion—Vertigo—Prednisone—multiple sclerosis	0.000116	0.00039	CcSEcCtD
Bupropion—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000116	0.00364	CbGpPWpGaD
Bupropion—Eye disorder—Methotrexate—multiple sclerosis	0.000115	0.000389	CcSEcCtD
Bupropion—Syncope—Prednisone—multiple sclerosis	0.000115	0.000389	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—multiple sclerosis	0.000115	0.000388	CcSEcCtD
Bupropion—Anorexia—Betamethasone—multiple sclerosis	0.000115	0.000387	CcSEcCtD
Bupropion—Anorexia—Dexamethasone—multiple sclerosis	0.000115	0.000387	CcSEcCtD
Bupropion—Urticaria—Prednisolone—multiple sclerosis	0.000115	0.000387	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—multiple sclerosis	0.000115	0.000386	CcSEcCtD
Bupropion—Fatigue—Triamcinolone—multiple sclerosis	0.000115	0.000386	CcSEcCtD
Bupropion—Fatigue—Methylprednisolone—multiple sclerosis	0.000114	0.000385	CcSEcCtD
Bupropion—Pain—Triamcinolone—multiple sclerosis	0.000114	0.000383	CcSEcCtD
Bupropion—Loss of consciousness—Prednisone—multiple sclerosis	0.000113	0.000381	CcSEcCtD
Bupropion—Hypotension—Betamethasone—multiple sclerosis	0.000113	0.00038	CcSEcCtD
Bupropion—Hypotension—Dexamethasone—multiple sclerosis	0.000113	0.00038	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000113	0.00354	CbGpPWpGaD
Bupropion—Angiopathy—Methotrexate—multiple sclerosis	0.000112	0.000378	CcSEcCtD
Bupropion—Vomiting—Mitoxantrone—multiple sclerosis	0.000112	0.000377	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—multiple sclerosis	0.000112	0.000376	CcSEcCtD
Bupropion—Convulsion—Prednisone—multiple sclerosis	0.000112	0.000376	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000111	0.000375	CcSEcCtD
Bupropion—Hypertension—Prednisone—multiple sclerosis	0.000111	0.000374	CcSEcCtD
Bupropion—Rash—Mitoxantrone—multiple sclerosis	0.000111	0.000374	CcSEcCtD
Bupropion—Dermatitis—Mitoxantrone—multiple sclerosis	0.000111	0.000374	CcSEcCtD
Bupropion—Chills—Methotrexate—multiple sclerosis	0.000111	0.000374	CcSEcCtD
Bupropion—Headache—Mitoxantrone—multiple sclerosis	0.00011	0.000372	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00011	0.00037	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00011	0.00037	CcSEcCtD
Bupropion—Arthralgia—Prednisone—multiple sclerosis	0.00011	0.000369	CcSEcCtD
Bupropion—Myalgia—Prednisone—multiple sclerosis	0.00011	0.000369	CcSEcCtD
Bupropion—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00011	0.000369	CcSEcCtD
Bupropion—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000109	0.000368	CcSEcCtD
Bupropion—Anxiety—Prednisone—multiple sclerosis	0.000109	0.000368	CcSEcCtD
Bupropion—Alopecia—Methotrexate—multiple sclerosis	0.000109	0.000368	CcSEcCtD
Bupropion—Insomnia—Betamethasone—multiple sclerosis	0.000109	0.000368	CcSEcCtD
Bupropion—Insomnia—Dexamethasone—multiple sclerosis	0.000109	0.000368	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000109	0.000367	CcSEcCtD
Bupropion—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000108	0.000365	CcSEcCtD
Bupropion—Paraesthesia—Dexamethasone—multiple sclerosis	0.000108	0.000365	CcSEcCtD
Bupropion—Paraesthesia—Betamethasone—multiple sclerosis	0.000108	0.000365	CcSEcCtD
Bupropion—Discomfort—Prednisone—multiple sclerosis	0.000108	0.000365	CcSEcCtD
Bupropion—Mental disorder—Methotrexate—multiple sclerosis	0.000108	0.000365	CcSEcCtD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000108	0.00339	CbGpPWpGaD
Bupropion—Malnutrition—Methotrexate—multiple sclerosis	0.000108	0.000362	CcSEcCtD
Bupropion—Hypersensitivity—Prednisolone—multiple sclerosis	0.000107	0.000359	CcSEcCtD
Bupropion—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000106	0.00334	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000106	0.00334	CbGpPWpGaD
Bupropion—Dyspepsia—Dexamethasone—multiple sclerosis	0.000106	0.000358	CcSEcCtD
Bupropion—Dyspepsia—Betamethasone—multiple sclerosis	0.000106	0.000358	CcSEcCtD
Bupropion—Urticaria—Triamcinolone—multiple sclerosis	0.000106	0.000356	CcSEcCtD
Bupropion—SLC6A3—Monoamine Transport—TNF—multiple sclerosis	0.000106	0.00332	CbGpPWpGaD
Bupropion—Urticaria—Methylprednisolone—multiple sclerosis	0.000105	0.000355	CcSEcCtD
Bupropion—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000105	0.00331	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000105	0.00331	CbGpPWpGaD
Bupropion—Dysgeusia—Methotrexate—multiple sclerosis	0.000105	0.000355	CcSEcCtD
Bupropion—Body temperature increased—Triamcinolone—multiple sclerosis	0.000105	0.000354	CcSEcCtD
Bupropion—Oedema—Prednisone—multiple sclerosis	0.000105	0.000354	CcSEcCtD
Bupropion—Anaphylactic shock—Prednisone—multiple sclerosis	0.000105	0.000354	CcSEcCtD
Bupropion—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000105	0.000353	CcSEcCtD
Bupropion—Decreased appetite—Dexamethasone—multiple sclerosis	0.000105	0.000353	CcSEcCtD
Bupropion—Decreased appetite—Betamethasone—multiple sclerosis	0.000105	0.000353	CcSEcCtD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000105	0.0033	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000105	0.0033	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000105	0.0033	CbGpPWpGaD
Bupropion—Nausea—Mitoxantrone—multiple sclerosis	0.000105	0.000353	CcSEcCtD
Bupropion—Infection—Prednisone—multiple sclerosis	0.000104	0.000352	CcSEcCtD
Bupropion—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000104	0.000351	CcSEcCtD
Bupropion—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000104	0.000351	CcSEcCtD
Bupropion—Back pain—Methotrexate—multiple sclerosis	0.000104	0.000351	CcSEcCtD
Bupropion—Fatigue—Dexamethasone—multiple sclerosis	0.000104	0.00035	CcSEcCtD
Bupropion—Fatigue—Betamethasone—multiple sclerosis	0.000104	0.00035	CcSEcCtD
Bupropion—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000104	0.00327	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000104	0.00327	CbGpPWpGaD
Bupropion—Shock—Prednisone—multiple sclerosis	0.000103	0.000348	CcSEcCtD
Bupropion—Pain—Betamethasone—multiple sclerosis	0.000103	0.000347	CcSEcCtD
Bupropion—Pain—Dexamethasone—multiple sclerosis	0.000103	0.000347	CcSEcCtD
Bupropion—Nervous system disorder—Prednisone—multiple sclerosis	0.000103	0.000347	CcSEcCtD
Bupropion—Tachycardia—Prednisone—multiple sclerosis	0.000103	0.000345	CcSEcCtD
Bupropion—Skin disorder—Prednisone—multiple sclerosis	0.000102	0.000344	CcSEcCtD
Bupropion—Hyperhidrosis—Prednisone—multiple sclerosis	0.000102	0.000342	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—multiple sclerosis	0.000101	0.000342	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000101	0.00316	CbGpPWpGaD
Bupropion—Anorexia—Prednisone—multiple sclerosis	0.0001	0.000337	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—multiple sclerosis	9.98e-05	0.000336	CcSEcCtD
Bupropion—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	9.95e-05	0.00313	CbGpPWpGaD
Bupropion—Anaemia—Methotrexate—multiple sclerosis	9.94e-05	0.000335	CcSEcCtD
Bupropion—Feeling abnormal—Betamethasone—multiple sclerosis	9.94e-05	0.000335	CcSEcCtD
Bupropion—Feeling abnormal—Dexamethasone—multiple sclerosis	9.94e-05	0.000335	CcSEcCtD
Bupropion—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.9e-05	0.00311	CbGpPWpGaD
Bupropion—Gastrointestinal pain—Dexamethasone—multiple sclerosis	9.86e-05	0.000332	CcSEcCtD
Bupropion—Gastrointestinal pain—Betamethasone—multiple sclerosis	9.86e-05	0.000332	CcSEcCtD
Bupropion—Hypersensitivity—Triamcinolone—multiple sclerosis	9.8e-05	0.00033	CcSEcCtD
Bupropion—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	9.79e-05	0.00308	CbGpPWpGaD
Bupropion—Hypersensitivity—Methylprednisolone—multiple sclerosis	9.77e-05	0.000329	CcSEcCtD
Bupropion—Malaise—Methotrexate—multiple sclerosis	9.7e-05	0.000327	CcSEcCtD
Bupropion—Vertigo—Methotrexate—multiple sclerosis	9.67e-05	0.000326	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—multiple sclerosis	9.63e-05	0.000324	CcSEcCtD
Bupropion—Urticaria—Betamethasone—multiple sclerosis	9.58e-05	0.000323	CcSEcCtD
Bupropion—Urticaria—Dexamethasone—multiple sclerosis	9.58e-05	0.000323	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.57e-05	0.000322	CcSEcCtD
Bupropion—Dizziness—Prednisolone—multiple sclerosis	9.56e-05	0.000322	CcSEcCtD
Bupropion—Asthenia—Triamcinolone—multiple sclerosis	9.54e-05	0.000321	CcSEcCtD
Bupropion—Body temperature increased—Betamethasone—multiple sclerosis	9.54e-05	0.000321	CcSEcCtD
Bupropion—Abdominal pain—Dexamethasone—multiple sclerosis	9.54e-05	0.000321	CcSEcCtD
Bupropion—Abdominal pain—Betamethasone—multiple sclerosis	9.54e-05	0.000321	CcSEcCtD
Bupropion—Body temperature increased—Dexamethasone—multiple sclerosis	9.54e-05	0.000321	CcSEcCtD
Bupropion—Asthenia—Methylprednisolone—multiple sclerosis	9.52e-05	0.000321	CcSEcCtD
Bupropion—Insomnia—Prednisone—multiple sclerosis	9.5e-05	0.00032	CcSEcCtD
Bupropion—Paraesthesia—Prednisone—multiple sclerosis	9.43e-05	0.000318	CcSEcCtD
Bupropion—Pruritus—Triamcinolone—multiple sclerosis	9.41e-05	0.000317	CcSEcCtD
Bupropion—Cough—Methotrexate—multiple sclerosis	9.39e-05	0.000316	CcSEcCtD
Bupropion—Pruritus—Methylprednisolone—multiple sclerosis	9.39e-05	0.000316	CcSEcCtD
Bupropion—Convulsion—Methotrexate—multiple sclerosis	9.32e-05	0.000314	CcSEcCtD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.29e-05	0.00292	CbGpPWpGaD
Bupropion—Dyspepsia—Prednisone—multiple sclerosis	9.25e-05	0.000311	CcSEcCtD
Bupropion—Chest pain—Methotrexate—multiple sclerosis	9.16e-05	0.000309	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—multiple sclerosis	9.16e-05	0.000309	CcSEcCtD
Bupropion—Myalgia—Methotrexate—multiple sclerosis	9.16e-05	0.000309	CcSEcCtD
Bupropion—Decreased appetite—Prednisone—multiple sclerosis	9.13e-05	0.000308	CcSEcCtD
Bupropion—Rash—Prednisolone—multiple sclerosis	9.12e-05	0.000307	CcSEcCtD
Bupropion—Dermatitis—Prednisolone—multiple sclerosis	9.11e-05	0.000307	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.1e-05	0.000306	CcSEcCtD
Bupropion—Diarrhoea—Methylprednisolone—multiple sclerosis	9.08e-05	0.000306	CcSEcCtD
Bupropion—Fatigue—Prednisone—multiple sclerosis	9.06e-05	0.000305	CcSEcCtD
Bupropion—Headache—Prednisolone—multiple sclerosis	9.06e-05	0.000305	CcSEcCtD
Bupropion—Discomfort—Methotrexate—multiple sclerosis	9.05e-05	0.000305	CcSEcCtD
Bupropion—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	9e-05	0.00283	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	9e-05	0.00283	CbGpPWpGaD
Bupropion—Constipation—Prednisone—multiple sclerosis	8.98e-05	0.000303	CcSEcCtD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.91e-05	0.0028	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.88e-05	0.00279	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.88e-05	0.00279	CbGpPWpGaD
Bupropion—Confusional state—Methotrexate—multiple sclerosis	8.85e-05	0.000298	CcSEcCtD
Bupropion—Dizziness—Triamcinolone—multiple sclerosis	8.79e-05	0.000296	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—multiple sclerosis	8.78e-05	0.000296	CcSEcCtD
Bupropion—Dizziness—Methylprednisolone—multiple sclerosis	8.77e-05	0.000295	CcSEcCtD
Bupropion—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.75e-05	0.00275	CbGpPWpGaD
Bupropion—Infection—Methotrexate—multiple sclerosis	8.72e-05	0.000294	CcSEcCtD
Bupropion—Feeling abnormal—Prednisone—multiple sclerosis	8.66e-05	0.000292	CcSEcCtD
Bupropion—Asthenia—Dexamethasone—multiple sclerosis	8.66e-05	0.000292	CcSEcCtD
Bupropion—Asthenia—Betamethasone—multiple sclerosis	8.66e-05	0.000292	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—multiple sclerosis	8.61e-05	0.00029	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—multiple sclerosis	8.6e-05	0.00029	CcSEcCtD
Bupropion—Gastrointestinal pain—Prednisone—multiple sclerosis	8.59e-05	0.000289	CcSEcCtD
Bupropion—Nausea—Prednisolone—multiple sclerosis	8.59e-05	0.000289	CcSEcCtD
Bupropion—Pruritus—Betamethasone—multiple sclerosis	8.54e-05	0.000287	CcSEcCtD
Bupropion—Pruritus—Dexamethasone—multiple sclerosis	8.54e-05	0.000287	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—multiple sclerosis	8.53e-05	0.000287	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—multiple sclerosis	8.49e-05	0.000286	CcSEcCtD
Bupropion—Vomiting—Triamcinolone—multiple sclerosis	8.45e-05	0.000285	CcSEcCtD
Bupropion—Vomiting—Methylprednisolone—multiple sclerosis	8.43e-05	0.000284	CcSEcCtD
Bupropion—Rash—Triamcinolone—multiple sclerosis	8.38e-05	0.000282	CcSEcCtD
Bupropion—Dermatitis—Triamcinolone—multiple sclerosis	8.38e-05	0.000282	CcSEcCtD
Bupropion—Anorexia—Methotrexate—multiple sclerosis	8.37e-05	0.000282	CcSEcCtD
Bupropion—Rash—Methylprednisolone—multiple sclerosis	8.36e-05	0.000282	CcSEcCtD
Bupropion—Dermatitis—Methylprednisolone—multiple sclerosis	8.36e-05	0.000281	CcSEcCtD
Bupropion—Urticaria—Prednisone—multiple sclerosis	8.35e-05	0.000281	CcSEcCtD
Bupropion—Headache—Triamcinolone—multiple sclerosis	8.33e-05	0.000281	CcSEcCtD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.32e-05	0.00262	CbGpPWpGaD
Bupropion—Headache—Methylprednisolone—multiple sclerosis	8.31e-05	0.00028	CcSEcCtD
Bupropion—Abdominal pain—Prednisone—multiple sclerosis	8.31e-05	0.00028	CcSEcCtD
Bupropion—Body temperature increased—Prednisone—multiple sclerosis	8.31e-05	0.00028	CcSEcCtD
Bupropion—Diarrhoea—Betamethasone—multiple sclerosis	8.25e-05	0.000278	CcSEcCtD
Bupropion—Diarrhoea—Dexamethasone—multiple sclerosis	8.25e-05	0.000278	CcSEcCtD
Bupropion—Hypotension—Methotrexate—multiple sclerosis	8.2e-05	0.000276	CcSEcCtD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.03e-05	0.00252	CbGpPWpGaD
Bupropion—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8e-05	0.000269	CcSEcCtD
Bupropion—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.99e-05	0.00251	CbGpPWpGaD
Bupropion—Dizziness—Betamethasone—multiple sclerosis	7.98e-05	0.000269	CcSEcCtD
Bupropion—Dizziness—Dexamethasone—multiple sclerosis	7.98e-05	0.000269	CcSEcCtD
Bupropion—Insomnia—Methotrexate—multiple sclerosis	7.94e-05	0.000267	CcSEcCtD
Bupropion—Nausea—Triamcinolone—multiple sclerosis	7.9e-05	0.000266	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—multiple sclerosis	7.88e-05	0.000266	CcSEcCtD
Bupropion—Nausea—Methylprednisolone—multiple sclerosis	7.88e-05	0.000265	CcSEcCtD
Bupropion—Dyspnoea—Methotrexate—multiple sclerosis	7.83e-05	0.000264	CcSEcCtD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.82e-05	0.00246	CbGpPWpGaD
Bupropion—Somnolence—Methotrexate—multiple sclerosis	7.81e-05	0.000263	CcSEcCtD
Bupropion—Hypersensitivity—Prednisone—multiple sclerosis	7.74e-05	0.000261	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—multiple sclerosis	7.73e-05	0.00026	CcSEcCtD
Bupropion—Vomiting—Dexamethasone—multiple sclerosis	7.67e-05	0.000258	CcSEcCtD
Bupropion—Vomiting—Betamethasone—multiple sclerosis	7.67e-05	0.000258	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—multiple sclerosis	7.63e-05	0.000257	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.62e-05	0.0024	CbGpPWpGaD
Bupropion—Rash—Betamethasone—multiple sclerosis	7.61e-05	0.000256	CcSEcCtD
Bupropion—Rash—Dexamethasone—multiple sclerosis	7.61e-05	0.000256	CcSEcCtD
Bupropion—Dermatitis—Betamethasone—multiple sclerosis	7.6e-05	0.000256	CcSEcCtD
Bupropion—Dermatitis—Dexamethasone—multiple sclerosis	7.6e-05	0.000256	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.58e-05	0.000255	CcSEcCtD
Bupropion—Fatigue—Methotrexate—multiple sclerosis	7.57e-05	0.000255	CcSEcCtD
Bupropion—Headache—Betamethasone—multiple sclerosis	7.56e-05	0.000255	CcSEcCtD
Bupropion—Headache—Dexamethasone—multiple sclerosis	7.56e-05	0.000255	CcSEcCtD
Bupropion—Asthenia—Prednisone—multiple sclerosis	7.54e-05	0.000254	CcSEcCtD
Bupropion—Pain—Methotrexate—multiple sclerosis	7.51e-05	0.000253	CcSEcCtD
Bupropion—Pruritus—Prednisone—multiple sclerosis	7.43e-05	0.00025	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—multiple sclerosis	7.24e-05	0.000244	CcSEcCtD
Bupropion—Diarrhoea—Prednisone—multiple sclerosis	7.19e-05	0.000242	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.18e-05	0.000242	CcSEcCtD
Bupropion—Nausea—Betamethasone—multiple sclerosis	7.17e-05	0.000241	CcSEcCtD
Bupropion—Nausea—Dexamethasone—multiple sclerosis	7.17e-05	0.000241	CcSEcCtD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.04e-05	0.00221	CbGpPWpGaD
Bupropion—Urticaria—Methotrexate—multiple sclerosis	6.98e-05	0.000235	CcSEcCtD
Bupropion—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.95e-05	0.00219	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.95e-05	0.00219	CbGpPWpGaD
Bupropion—Dizziness—Prednisone—multiple sclerosis	6.95e-05	0.000234	CcSEcCtD
Bupropion—Abdominal pain—Methotrexate—multiple sclerosis	6.94e-05	0.000234	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—multiple sclerosis	6.94e-05	0.000234	CcSEcCtD
Bupropion—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.85e-05	0.00216	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.85e-05	0.00216	CbGpPWpGaD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.76e-05	0.00213	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.75e-05	0.00212	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—BCHE—multiple sclerosis	6.71e-05	0.00211	CbGpPWpGaD
Bupropion—Vomiting—Prednisone—multiple sclerosis	6.68e-05	0.000225	CcSEcCtD
Bupropion—Rash—Prednisone—multiple sclerosis	6.62e-05	0.000223	CcSEcCtD
Bupropion—Dermatitis—Prednisone—multiple sclerosis	6.62e-05	0.000223	CcSEcCtD
Bupropion—Headache—Prednisone—multiple sclerosis	6.58e-05	0.000222	CcSEcCtD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.48e-05	0.00204	CbGpPWpGaD
Bupropion—Hypersensitivity—Methotrexate—multiple sclerosis	6.47e-05	0.000218	CcSEcCtD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.34e-05	0.00199	CbGpPWpGaD
Bupropion—Asthenia—Methotrexate—multiple sclerosis	6.3e-05	0.000212	CcSEcCtD
Bupropion—Nausea—Prednisone—multiple sclerosis	6.24e-05	0.00021	CcSEcCtD
Bupropion—Pruritus—Methotrexate—multiple sclerosis	6.21e-05	0.000209	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.03e-05	0.0019	CbGpPWpGaD
Bupropion—Diarrhoea—Methotrexate—multiple sclerosis	6.01e-05	0.000202	CcSEcCtD
Bupropion—Dizziness—Methotrexate—multiple sclerosis	5.81e-05	0.000196	CcSEcCtD
Bupropion—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	5.78e-05	0.00182	CbGpPWpGaD
Bupropion—Vomiting—Methotrexate—multiple sclerosis	5.58e-05	0.000188	CcSEcCtD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.55e-05	0.00175	CbGpPWpGaD
Bupropion—Rash—Methotrexate—multiple sclerosis	5.54e-05	0.000186	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—multiple sclerosis	5.53e-05	0.000186	CcSEcCtD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.5e-05	0.00173	CbGpPWpGaD
Bupropion—Headache—Methotrexate—multiple sclerosis	5.5e-05	0.000185	CcSEcCtD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.48e-05	0.00172	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.34e-05	0.00168	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.33e-05	0.00168	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.29e-05	0.00166	CbGpPWpGaD
Bupropion—Nausea—Methotrexate—multiple sclerosis	5.22e-05	0.000176	CcSEcCtD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.97e-05	0.00156	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.97e-05	0.00156	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.84e-05	0.00152	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.72e-05	0.00148	CbGpPWpGaD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.7e-05	0.00148	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SRM—multiple sclerosis	4.6e-05	0.00145	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.5e-05	0.00142	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.46e-05	0.0014	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.32e-05	0.00136	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.3e-05	0.00135	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—POMC—multiple sclerosis	4.26e-05	0.00134	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—MAPK1—multiple sclerosis	4.06e-05	0.00128	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.05e-05	0.00127	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.05e-05	0.00127	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.81e-05	0.0012	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	3.79e-05	0.00119	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.77e-05	0.00119	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SRM—multiple sclerosis	3.71e-05	0.00117	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SRM—multiple sclerosis	3.64e-05	0.00114	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.63e-05	0.00114	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.46e-05	0.00109	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.46e-05	0.00109	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.44e-05	0.00108	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.37e-05	0.00106	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.36e-05	0.00106	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	3.36e-05	0.00106	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.35e-05	0.00105	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.34e-05	0.00105	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.29e-05	0.00103	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.24e-05	0.00102	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.24e-05	0.00102	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SRM—multiple sclerosis	3.14e-05	0.000988	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.13e-05	0.000985	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.13e-05	0.000985	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.96e-05	0.000932	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.94e-05	0.000925	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.91e-05	0.000916	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2.8e-05	0.000881	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.62e-05	0.000822	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.62e-05	0.000822	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SRM—multiple sclerosis	2.58e-05	0.000811	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.56e-05	0.000806	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.56e-05	0.000806	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.56e-05	0.000805	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SRM—multiple sclerosis	2.56e-05	0.000804	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.46e-05	0.000772	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.39e-05	0.000752	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.39e-05	0.000752	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.37e-05	0.000745	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.34e-05	0.000737	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.21e-05	0.000696	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.21e-05	0.000696	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SRM—multiple sclerosis	2.19e-05	0.000687	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.16e-05	0.000681	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.03e-05	0.000637	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000637	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.98e-05	0.000623	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	1.96e-05	0.000616	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.94e-05	0.00061	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.92e-05	0.000603	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.82e-05	0.000572	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.82e-05	0.000572	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.8e-05	0.000567	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.8e-05	0.000567	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.76e-05	0.000554	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.7e-05	0.000534	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SRM—multiple sclerosis	1.69e-05	0.00053	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000528	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.66e-05	0.000523	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.65e-05	0.000518	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.56e-05	0.000492	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.54e-05	0.000484	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.54e-05	0.000484	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.5e-05	0.000473	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.41e-05	0.000444	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.41e-05	0.000443	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.000433	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.37e-05	0.000429	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.3e-05	0.000409	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.19e-05	0.000374	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.19e-05	0.000374	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.000367	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000358	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000352	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.11e-05	0.000351	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.09e-05	0.000342	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.06e-05	0.000333	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	0.000321	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—BCHE—multiple sclerosis	9.64e-06	0.000303	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.1e-06	0.000286	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.05e-06	0.000285	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.01e-06	0.000283	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—APOE—multiple sclerosis	8.49e-06	0.000267	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.3e-06	0.000261	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.91e-06	0.000249	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.84e-06	0.000247	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.78e-06	0.000245	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—POMC—multiple sclerosis	7.29e-06	0.000229	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.09e-06	0.000223	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—APOE—multiple sclerosis	6.85e-06	0.000215	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—APOE—multiple sclerosis	6.71e-06	0.000211	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.7e-06	0.000211	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ALB—multiple sclerosis	6.65e-06	0.000209	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—POMC—multiple sclerosis	5.88e-06	0.000185	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—APOE—multiple sclerosis	5.8e-06	0.000182	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—POMC—multiple sclerosis	5.76e-06	0.000181	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ALB—multiple sclerosis	5.36e-06	0.000169	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ALB—multiple sclerosis	5.25e-06	0.000165	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.17e-06	0.000163	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—POMC—multiple sclerosis	4.98e-06	0.000157	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—APOE—multiple sclerosis	4.76e-06	0.00015	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—APOE—multiple sclerosis	4.72e-06	0.000148	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ALB—multiple sclerosis	4.54e-06	0.000143	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—POMC—multiple sclerosis	4.09e-06	0.000129	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—POMC—multiple sclerosis	4.05e-06	0.000127	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—APOE—multiple sclerosis	4.03e-06	0.000127	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ALB—multiple sclerosis	3.73e-06	0.000117	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ALB—multiple sclerosis	3.7e-06	0.000116	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—POMC—multiple sclerosis	3.46e-06	0.000109	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ALB—multiple sclerosis	3.16e-06	9.93e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—APOE—multiple sclerosis	3.11e-06	9.79e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—POMC—multiple sclerosis	2.67e-06	8.41e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ALB—multiple sclerosis	2.44e-06	7.66e-05	CbGpPWpGaD
